These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26206516)

  • 1. Quality assurance of radiation therapy for head and neck cancer patients treated in DAHANCA 10 randomized trial.
    Hansen CR; Johansen J; Kristensen CA; Smulders B; Andersen LJ; Samsøe E; Andersen E; Petersen JB; Overgaard J; Grau C
    Acta Oncol; 2015; 54(9):1669-73. PubMed ID: 26206516
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiotherapy quality assurance of the IAEA-HypoX trial of the accelerated radiotherapy in the treatment of head and neck squamous cell carcinoma with or without the hypoxic radiosensitizer nimorazole.
    Hassan Metwally MA; Ali R; Kuddu M; Shouman T; Strojan P; Overgaard J; Grau C
    Acta Oncol; 2015; 54(9):1673-7. PubMed ID: 26397148
    [No Abstract]   [Full Text] [Related]  

  • 3. Altered fractionation for head and neck cancer.
    Garden AS
    Oncology (Williston Park); 2001 Oct; 15(10):1326-32, 1334; discussion 1334, 1339-41. PubMed ID: 11702960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality assurance in head and neck surgical oncology: EORTC 24954 trial on larynx preservation.
    Leemans CR; Tijink BM; Langendijk JA; Andry G; Hamoir M; Lefebvre JL;
    Eur J Surg Oncol; 2013 Sep; 39(9):1013-8. PubMed ID: 23810332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality assurance audit in an Australasian phase III trial of accelerated radiotherapy for head and neck cancer (TROG 91.01). Trans-Tasman Radiation Oncology Group.
    Hamilton C; Poulsen M; Walker Q; Krawitz H; Hindley A; Spry N; Peters L; Lamb D; Denham J; Steigler A
    Australas Radiol; 1999 May; 43(2):227-32. PubMed ID: 10901907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality assurance of radiotherapy in the ongoing EORTC 1219-DAHANCA-29 trial for HPV/p16 negative squamous cell carcinoma of the head and neck: Results of the benchmark case procedure.
    Christiaens M; Collette S; Overgaard J; Gregoire V; Kazmierska J; Castadot P; Giralt J; Grant W; Tomsej M; Bar-Deroma R; Monti AF; Hurkmans CW; Weber DC
    Radiother Oncol; 2017 Jun; 123(3):424-430. PubMed ID: 28478912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck.
    Haffty BG; Son YH; Wilson LD; Papac R; Fischer D; Rockwell S; Sartorelli AC; Ross D; Sasaki CT; Fischer JJ
    Radiat Oncol Investig; 1997; 5(5):235-45. PubMed ID: 9372546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head and neck cancer: altered fractionation schedules.
    Saunders MI
    Oncologist; 1999; 4(1):11-6. PubMed ID: 10337367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status of accelerated fractionation radiotherapy in head and neck squamous cell carcinomas.
    Bourhis J; Wibault P; Lusinchi A; Bobin S; Luboinski B; Eschwege F
    Curr Opin Oncol; 1997 May; 9(3):262-6. PubMed ID: 9229149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quality criteria in radiotherapy for head and neck cancers under the aegis of Head and Neck Intergroup].
    Tao Y; Vintonenko N; Garcia R; Marchesi V; Tomsej M; Bardet E; Bourhis J
    Bull Cancer; 2014 May; 101(5):481-5. PubMed ID: 24886899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas.
    Khalil AA; Bentzen SM; Bernier J; Saunders MI; Horiot JC; Van Den Bogaert W; Cummings BJ; Dische S
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):568-75. PubMed ID: 12573743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!
    Dubben HH; Beck-Bornholdt HP
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):563. PubMed ID: 11579925
    [No Abstract]   [Full Text] [Related]  

  • 13. Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02.
    Peters LJ; O'Sullivan B; Giralt J; Fitzgerald TJ; Trotti A; Bernier J; Bourhis J; Yuen K; Fisher R; Rischin D
    J Clin Oncol; 2010 Jun; 28(18):2996-3001. PubMed ID: 20479390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of induction chemotherapy for head and neck squamous cell carcinoma.
    Haigentz M; Cohen EE; Wolf GT; Strojan P; Eisbruch A; Ferlito A
    Oral Oncol; 2012 Nov; 48(11):1065-7. PubMed ID: 22981388
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
    Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
    Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IAEA-ACC study: a commendable start.
    Corry J
    Lancet Oncol; 2010 Jun; 11(6):503-4. PubMed ID: 20522372
    [No Abstract]   [Full Text] [Related]  

  • 17. [DAHANCA (Danish Head and Neck Cancer)--20 years of cooperation].
    Hansen HS; Overgaard J; Jørgensen KE
    Ugeskr Laeger; 1998 Feb; 160(6):821-6. PubMed ID: 9469979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma.
    Rosenthal DI; Ang KK
    Semin Radiat Oncol; 2004 Apr; 14(2):153-66. PubMed ID: 15095261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mature results of a randomized trial of accelerated hyperfractionated versus conventional radiotherapy in head-and-neck cancer.
    Saunders MI; Rojas AM; Parmar MK; Dische S;
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):3-8. PubMed ID: 20394851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current status of phase III study of combined treatment with radiotherapy and chemotherapy for head and neck cancer].
    Inoue T; Inoue T; Murayama S
    Gan To Kagaku Ryoho; 1995 Feb; 22(3):350-6. PubMed ID: 7880105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.